1,1-dichloroethene increases expression ISO Knl1 (Mus musculus) 6480464 vinylidene chloride results in increased expression of KNL1 mRNA CTD PMID:26682919 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of KNL1 mRNA CTD PMID:30723492 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KNL1 mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KNL1 mRNA CTD PMID:32741896 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression ISO KNL1 (Homo sapiens) 6480464 Metribolone results in increased expression of KNL1 mRNA CTD PMID:17010196 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO KNL1 (Homo sapiens) 6480464 2 more ... CTD PMID:31173147 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Knl1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of KNL1 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of KNL1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of KNL1 mRNA CTD PMID:32109520 and PMID:33387578 3,4-dichloroaniline decreases expression ISO KNL1 (Homo sapiens) 6480464 3 and 4-dichloroaniline results in decreased expression of KNL1 mRNA CTD PMID:24172598 3,7-dihydropurine-6-thione decreases expression EXP 6480464 Mercaptopurine results in decreased expression of KNL1 mRNA CTD PMID:23358152 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO KNL1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of KNL1 mRNA CTD PMID:28628672 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of KNL1 mRNA CTD PMID:24780913 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of KNL1 mRNA CTD PMID:25825206 acetamide increases expression EXP 6480464 acetamide results in increased expression of KNL1 mRNA CTD PMID:31881176 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of KNL1 mRNA CTD PMID:28959563 acrylamide decreases expression ISO KNL1 (Homo sapiens) 6480464 Acrylamide results in decreased expression of KNL1 mRNA CTD PMID:32763439 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of KNL1 mRNA CTD PMID:25378103 aflatoxin M1 decreases expression ISO KNL1 (Homo sapiens) 6480464 Aflatoxin M1 results in decreased expression of KNL1 mRNA CTD PMID:30928695 aldehydo-D-glucose multiple interactions ISO Knl1 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of KNL1 mRNA CTD PMID:37567420 all-trans-retinoic acid decreases expression ISO KNL1 (Homo sapiens) 6480464 Tretinoin results in decreased expression of KNL1 mRNA CTD PMID:33167477 antirheumatic drug decreases expression ISO KNL1 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of KNL1 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO KNL1 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of KNL1 mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO KNL1 (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to KNL1 mRNA] CTD PMID:32406909 benzo[a]pyrene increases expression ISO Knl1 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of KNL1 mRNA CTD PMID:32417428 benzo[a]pyrene diol epoxide I decreases expression ISO KNL1 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 and PMID:20382639 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of KNL1 mRNA CTD PMID:25181051 and PMID:34947998 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of KNL1 mRNA CTD PMID:32145629 bisphenol A decreases expression ISO KNL1 (Homo sapiens) 6480464 bisphenol A results in decreased expression of KNL1 mRNA CTD PMID:29275510 bisphenol A multiple interactions ISO KNL1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of KNL1 mRNA CTD PMID:28628672 butanal decreases expression ISO KNL1 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of KNL1 mRNA CTD PMID:26079696 cadmium dichloride decreases expression ISO Knl1 (Mus musculus) 6480464 Cadmium Chloride results in decreased expression of KNL1 mRNA CTD PMID:24982889 caffeine affects phosphorylation ISO KNL1 (Homo sapiens) 6480464 Caffeine affects the phosphorylation of KNL1 protein CTD PMID:35688186 calcitriol decreases expression ISO KNL1 (Homo sapiens) 6480464 Calcitriol results in decreased expression of KNL1 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO KNL1 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of KNL1 mRNA CTD PMID:21592394 carbon nanotube increases expression ISO Knl1 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 chlorpyrifos decreases expression ISO Knl1 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of KNL1 mRNA CTD PMID:37019170 choline multiple interactions ISO Knl1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of KNL1 gene CTD PMID:20938992 clobetasol decreases expression ISO Knl1 (Mus musculus) 6480464 Clobetasol results in decreased expression of KNL1 mRNA CTD PMID:27462272 cobalt dichloride decreases expression ISO KNL1 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of KNL1 mRNA CTD PMID:19320972 copper(II) sulfate decreases expression ISO KNL1 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of KNL1 mRNA CTD PMID:19549813 coumestrol multiple interactions ISO KNL1 (Homo sapiens) 6480464 [Coumestrol co-treated with Resveratrol] results in increased expression of KNL1 mRNA CTD PMID:19167446 coumestrol increases expression ISO KNL1 (Homo sapiens) 6480464 Coumestrol results in increased expression of KNL1 mRNA CTD PMID:19167446 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of KNL1 mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO KNL1 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of KNL1 mRNA CTD PMID:21632981 D-glucose multiple interactions ISO Knl1 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of KNL1 mRNA CTD PMID:37567420 deguelin increases expression ISO KNL1 (Homo sapiens) 6480464 deguelin results in increased expression of KNL1 mRNA CTD PMID:33512557 dexamethasone multiple interactions ISO KNL1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of KNL1 mRNA CTD PMID:28628672 diallyl trisulfide decreases expression ISO KNL1 (Homo sapiens) 6480464 diallyl trisulfide results in decreased expression of KNL1 mRNA CTD PMID:34995734 dibutyl phthalate decreases expression ISO Knl1 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of KNL1 mRNA CTD PMID:17361019 dicrotophos decreases expression ISO KNL1 (Homo sapiens) 6480464 dicrotophos results in decreased expression of KNL1 mRNA CTD PMID:28302478 dimethylarsinic acid increases expression EXP 6480464 Cacodylic Acid results in increased expression of KNL1 mRNA CTD PMID:37567419 disodium selenite decreases expression ISO KNL1 (Homo sapiens) 6480464 Sodium Selenite results in decreased expression of KNL1 mRNA CTD PMID:24383545 diuron decreases expression ISO KNL1 (Homo sapiens) 6480464 Diuron metabolite results in decreased expression of KNL1 mRNA CTD PMID:24172598 dorsomorphin multiple interactions ISO KNL1 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KNL1 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO KNL1 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of KNL1 mRNA CTD PMID:29803840 and PMID:30031762 doxorubicin increases expression ISO Knl1 (Mus musculus) 6480464 Doxorubicin results in increased expression of KNL1 mRNA CTD PMID:36227756 fenpyroximate increases expression ISO KNL1 (Homo sapiens) 6480464 fenpyroximate results in increased expression of KNL1 mRNA CTD PMID:33512557 folic acid multiple interactions ISO Knl1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of KNL1 gene CTD PMID:20938992 folic acid multiple interactions ISO KNL1 (Homo sapiens) 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of KNL1 mRNA CTD PMID:24657277 FR900359 decreases phosphorylation ISO KNL1 (Homo sapiens) 6480464 FR900359 results in decreased phosphorylation of KNL1 protein CTD PMID:37730182 fructose multiple interactions ISO Knl1 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of KNL1 mRNA CTD PMID:37567420 furan increases expression EXP 6480464 furan results in increased expression of KNL1 mRNA CTD PMID:25539665 geldanamycin increases expression ISO KNL1 (Homo sapiens) 6480464 geldanamycin results in increased expression of KNL1 mRNA CTD PMID:26705709 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of KNL1 mRNA CTD PMID:33387578 glucose multiple interactions ISO Knl1 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of KNL1 mRNA CTD PMID:37567420 glyphosate multiple interactions ISO Knl1 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of KNL1 mRNA CTD PMID:37567420 Heliotrine increases expression EXP 6480464 heliotrine results in increased expression of KNL1 mRNA CTD PMID:32419051 hydrogen peroxide multiple interactions ISO Knl1 (Mus musculus) 6480464 [Hydrogen Peroxide co-treated with N-(oxo-5 more ... CTD PMID:31494107 indometacin multiple interactions ISO KNL1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of KNL1 mRNA CTD PMID:28628672 ivermectin decreases expression ISO KNL1 (Homo sapiens) 6480464 Ivermectin results in decreased expression of KNL1 protein CTD PMID:32959892 L-methionine multiple interactions ISO Knl1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of KNL1 gene CTD PMID:20938992 lead(0) affects expression ISO KNL1 (Homo sapiens) 6480464 Lead affects the expression of KNL1 mRNA CTD PMID:28903495 leflunomide decreases expression ISO KNL1 (Homo sapiens) 6480464 Leflunomide results in decreased expression of KNL1 mRNA CTD PMID:28988120 lucanthone decreases expression ISO KNL1 (Homo sapiens) 6480464 Lucanthone results in decreased expression of KNL1 mRNA CTD PMID:21148553 MeIQx increases expression ISO KNL1 (Homo sapiens) 6480464 2-amino-3 more ... CTD PMID:20816883 mercaptopurine decreases expression EXP 6480464 Mercaptopurine results in decreased expression of KNL1 mRNA CTD PMID:23358152 methotrexate multiple interactions ISO KNL1 (Homo sapiens) 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of KNL1 mRNA CTD PMID:24657277 methotrexate decreases expression ISO KNL1 (Homo sapiens) 6480464 Methotrexate results in decreased expression of KNL1 mRNA CTD PMID:24657277 N-Nitrosopyrrolidine decreases expression ISO KNL1 (Homo sapiens) 6480464 N-Nitrosopyrrolidine results in decreased expression of KNL1 mRNA CTD PMID:32234424 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of KNL1 mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of KNL1 mRNA CTD PMID:25729387 ozone multiple interactions ISO Knl1 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of KNL1 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of KNL1 mRNA CTD PMID:34911549 paracetamol increases expression ISO KNL1 (Homo sapiens) 6480464 Acetaminophen results in increased expression of KNL1 mRNA CTD PMID:22230336 pentanal decreases expression ISO KNL1 (Homo sapiens) 6480464 pentanal results in decreased expression of KNL1 mRNA CTD PMID:26079696 perfluorononanoic acid decreases expression ISO KNL1 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of KNL1 mRNA CTD PMID:32588087 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of KNL1 mRNA CTD PMID:31324951 picoxystrobin increases expression ISO KNL1 (Homo sapiens) 6480464 picoxystrobin results in increased expression of KNL1 mRNA CTD PMID:33512557 progesterone decreases expression ISO KNL1 (Homo sapiens) 6480464 Progesterone results in decreased expression of KNL1 mRNA CTD PMID:21795739 propanal decreases expression ISO KNL1 (Homo sapiens) 6480464 propionaldehyde results in decreased expression of KNL1 mRNA CTD PMID:26079696 purine-6-thiol decreases expression EXP 6480464 Mercaptopurine results in decreased expression of KNL1 mRNA CTD PMID:23358152 quercetin decreases expression ISO KNL1 (Homo sapiens) 6480464 Quercetin results in decreased expression of KNL1 mRNA CTD PMID:21632981 resveratrol multiple interactions ISO KNL1 (Homo sapiens) 6480464 [Coumestrol co-treated with Resveratrol] results in increased expression of KNL1 mRNA CTD PMID:19167446 rotenone increases expression ISO KNL1 (Homo sapiens) 6480464 Rotenone results in increased expression of KNL1 mRNA CTD PMID:33512557 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of KNL1 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO KNL1 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KNL1 mRNA CTD PMID:27188386 senecionine increases expression EXP 6480464 senecionine results in increased expression of KNL1 mRNA CTD PMID:32419051 Senkirkine increases expression EXP 6480464 senkirkine results in increased expression of KNL1 mRNA CTD PMID:32419051 silicon dioxide increases expression ISO Knl1 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of KNL1 mRNA CTD PMID:29341224 silver atom decreases expression ISO Knl1 (Mus musculus) 6480464 Silver results in decreased expression of KNL1 mRNA CTD PMID:27131904 silver(0) decreases expression ISO Knl1 (Mus musculus) 6480464 Silver results in decreased expression of KNL1 mRNA CTD PMID:27131904 sodium arsenate increases expression ISO Knl1 (Mus musculus) 6480464 sodium arsenate results in increased expression of KNL1 mRNA CTD PMID:30953684 sodium arsenite increases expression ISO KNL1 (Homo sapiens) 6480464 sodium arsenite results in increased expression of KNL1 mRNA CTD PMID:29301061 sunitinib decreases expression ISO KNL1 (Homo sapiens) 6480464 Sunitinib results in decreased expression of KNL1 mRNA CTD PMID:31533062 testosterone decreases expression ISO KNL1 (Homo sapiens) 6480464 Testosterone results in decreased expression of KNL1 mRNA CTD PMID:21592394 testosterone multiple interactions ISO KNL1 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of KNL1 mRNA CTD PMID:21592394 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KNL1 mRNA CTD PMID:32741896 tetrachloromethane increases expression ISO Knl1 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of KNL1 mRNA CTD PMID:29987408 and PMID:31919559 thimerosal decreases expression ISO KNL1 (Homo sapiens) 6480464 Thimerosal results in decreased expression of KNL1 mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of KNL1 mRNA CTD PMID:23411599 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of KNL1 mRNA CTD PMID:30012374 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of KNL1 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of KNL1 mRNA CTD PMID:25729387 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of KNL1 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO KNL1 (Homo sapiens) 6480464 trichostatin A results in decreased expression of KNL1 mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO KNL1 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KNL1 mRNA CTD PMID:27188386 triclosan decreases expression ISO KNL1 (Homo sapiens) 6480464 Triclosan results in decreased expression of KNL1 mRNA CTD PMID:30510588 trimellitic anhydride increases expression ISO Knl1 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of KNL1 mRNA CTD PMID:19042947 trovafloxacin decreases expression ISO Knl1 (Mus musculus) 6480464 trovafloxacin results in decreased expression of KNL1 mRNA CTD PMID:35537566 valproic acid decreases expression ISO KNL1 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of KNL1 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO KNL1 (Homo sapiens) 6480464 Valproic Acid affects the expression of KNL1 mRNA CTD PMID:25979313 valproic acid decreases methylation ISO KNL1 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of KNL1 gene CTD PMID:29154799 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of KNL1 mRNA CTD PMID:23555832 vorinostat decreases expression ISO KNL1 (Homo sapiens) 6480464 Vorinostat results in decreased expression of KNL1 mRNA CTD PMID:27188386